Dear Women's Imaging Insider,
Some say that digital breast tomosynthesis (DBT) is the best thing to happen to screening mammography since the modality shifted from film to digital.
Studies show that tomo finds more cancers than mammography alone and reduces recall rates. Researchers from Yale University say the technology offers another benefit: It's cost-effective, especially in the diagnostic setting. Learn more in this issue's Insider Exclusive.
When you've finished, check out what else is going on in the Women's Imaging Community. Among other stories, we have a number of articles covering presentations from meetings of the American Roentgen Ray Society, the American Society of Breast Surgeons, the National Consortium of Breast Centers, and the Society of Breast Imaging:
- Learn about two studies published this week in the Journal of the American Medical Association: one on whether breast density notification letters are understandable to patients and another on the effectiveness of DBT in both dense and nondense tissue.
- Researchers from Massachusetts General Hospital say that half of women younger than 45 have an elevated risk of breast cancer. Find out how they think this could affect screening protocols.
- Check out an article that questions whether we overtreat ductal carcinoma in situ: Dr. Sadia Khan of the University of Southern California thinks not. Read why she says it's crucial to continue to excise these cancers rather than "watch and wait."
- Discover how infertility treatments may boost breast density -- and therefore women's risk of cancer.
- Could department stores become the breast cancer screening sites of the future? Find out what a researcher from the Advisory Board Company in Washington, DC, has to say about how breast centers need to get creative in an era of consumer-driven healthcare.
As always, if you have a comment, report, or article idea to share about any aspect of women's imaging, please contact me.
